🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT00741884
We are interested in whether bunionectomy can be used as a model to study t...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00601458
Treatments Being Tested
Multiple system atrophy (MSA) is a rare, rapidly progressive, and invariabl...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2021-12-15
Trial ID
NCT05167721
Treatments Being Tested
Rosiglitazone (RSG) has been tested in clinical studies and is approved by ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-07-06
Trial ID
NCT00348309
Treatments Being Tested
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Status
Completed
Location
UAB HIVTR-CCR5 Non-Network CRS
Start Date
2017-01-01
Trial ID
NCT02741323
A combination therapy of NRCT-101 with NRCT-202 is being developed for pati...
Status
Terminated
Location
Accel Research Site-Maitland Clinical Research Unit
Start Date
2025-02-25
Trial ID
NCT06673368
Treatments Being Tested
This study evaluates the safety and tolerability of treatment with K0706 in...
Status
Terminated
Location
MedStar Georgetown University Hospital
Start Date
2019-09-05
Trial ID
NCT03996460
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of VRB-103...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-07-06
Trial ID
NCT07628127